Response of patients with sickle cell anaemia and end-stage renal disease to erythropoietin treatment.
作者信息
Zumrutdal Aysegul
机构信息
Nephrology Department, Adana Teaching and Research Center , Baskent University , Adana , Turkey.
出版信息
NDT Plus. 2010 Jun;3(3):328-330. doi: 10.1093/ndtplus/sfq011. Epub 2010 Feb 28.
Abstract
摘要
相似文献
1
Response of patients with sickle cell anaemia and end-stage renal disease to erythropoietin treatment.
NDT Plus. 2010 Jun;3(3):328-330. doi: 10.1093/ndtplus/sfq011. Epub 2010 Feb 28.
2
Erythropoietin response to anaemia in children with sickle cell disease and Fanconi's hypoproliferative anaemia.
Acta Haematol. 1985;74(1):6-9. doi: 10.1159/000206154.
3
Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure.
Nephrol Dial Transplant. 1992;7(8):817-21.
4
Is there a correlation between raised erythropoietin and thrombotic events in sickle-cell anaemia?
Lancet. 1998 Aug 15;352(9127):566-7. doi: 10.1016/S0140-6736(97)11506-9.
5
Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients.
Drugs Aging. 1995 Aug;7(2):131-56. doi: 10.2165/00002512-199507020-00007.
6
Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease.
BMJ. 1992 Feb 22;304(6825):474-7. doi: 10.1136/bmj.304.6825.474.
7
Erythropoietin levels and inhibition of erythropoiesis in end-stage renal failure.
Ann Acad Med Singap. 1991 Nov;20(6):755-7.
8
On the use of hydroxyurea/erythropoietin combination therapy for sickle cell disease.
Acta Haematol. 1995;94(3):128-34. doi: 10.1159/000203994.
9
Improvement of erythropoietin-resistant anaemia after renal transplantation in patients with homozygous sickle-cell disease.
Nephrol Dial Transplant. 1998 Nov;13(11):2949-52. doi: 10.1093/ndt/13.11.2949.
10
Treatment of anaemia of progressive renal failure with recombinant human erythropoietin. A preliminary report.
J Assoc Physicians India. 1992 Jan;40(1):42-3.
引用本文的文献
1
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease.
Blood Adv. 2019 Dec 10;3(23):3867-3897. doi: 10.1182/bloodadvances.2019000916.
本文引用的文献
1
A case report of darbepoetin treatment in a patient with sickle cell disease and chronic renal failure undergoing regular hemodialysis procedures that induce a dose-dependent extension of blood transfusion intervals.
Ther Apher Dial. 2009 Feb;13(1):80-2. doi: 10.1111/j.1744-9987.2009.00602.x.
2
Improvement of erythropoietin-resistant anaemia after renal transplantation in patients with homozygous sickle-cell disease.
Nephrol Dial Transplant. 1998 Nov;13(11):2949-52. doi: 10.1093/ndt/13.11.2949.
3
Is there a correlation between raised erythropoietin and thrombotic events in sickle-cell anaemia?
Lancet. 1998 Aug 15;352(9127):566-7. doi: 10.1016/S0140-6736(97)11506-9.
4
Effect of recombinant human erythropoietin on erythropoiesis in homozygous sickle-cell anaemia and renal failure.
Nephrol Dial Transplant. 1992;7(8):817-21.
Zotero 插件